nach oben

18.05.2024 | Original Article

Clinician response after receipt of abnormal pediatric ambulatory blood pressure monitoring – characteristics associated with inertia and action

verfasst von: Evelien van Gelderen, Kevin J. Psoter, Rafi Faria, Cozumel Pruette, Tammy M. Brady

Einloggen, um Zugang zu erhalten

Abstract

Background

Ambulatory Blood Pressure Monitoring (ABPM) is recommended for diagnosis and management of hypertension. We aimed to identify characteristics associated with physician action after receipt of abnormal findings.

Methods

This was a retrospective cross-sectional analysis of patients 5–22 years old who underwent 24-h ABPM between 2003–2022, met criteria for masked or ambulatory hypertension, and had a pediatric nephrology clinic visit within 2 weeks of ABPM. “Action” was defined as medication change/initiation, lifestyle or adherence counseling, evaluation ordered, or interpretation with no change. Characteristics of children with/without 1 or more actions were compared using Student t-tests and Chi-square. Regression analyses explored the independent association of patient characteristics with physician action.

Results

115 patients with masked (n = 53) and ambulatory (n = 62) hypertension were included: mean age 13.0 years, 48% female, 38% Black race, 21% with chronic kidney disease, and 25% overweight/obesity. 97 (84%) encounters had a documented physician action. Medication change (52%), evaluation ordered (40%), and prescribed lifestyle change (35%) were the most common actions. Adherence counseling for medication and lifestyle recommendations were documented in 3% of encounters. 24-h, wake SBP load, and sleep DBP load were significantly higher among those with physician action. Patients with > 1 action had greater adiposity, SBP, and dipping. Neither age, obesity, nor kidney disease were independently associated with physician action.

Conclusions

While most abnormal ABPMs were acted upon, 16% did not have a documented action. Greater BP load was one of the few characteristics associated with physician action. Of potential actions, adherence counseling was underutilized.

Graphical abstract

Nur mit Berechtigung zugänglich

CDC (2022) Heart disease facts. https://www.cdc.gov/heartdisease/index.htm

Candelino M, Tagi VM, Chiarelli F (2022) Cardiovascular risk in children: a burden for future generations. Ital J Pediatr 48:57. https://doi.org/10.1186/s13052-022-01250-5CrossRefPubMedPubMedCentral

de Ferranti SD, Steinberger J, Ameduri R et al (2019) Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association. Circulation 139:e603–e634. https://doi.org/10.1161/CIR.0000000000000618CrossRefPubMed

Song P, Zhang Y, Yu J et al (2019) Global prevalence of hypertension in children: a systematic review and meta-analysis. JAMA Pediatr 173:1154–1163. https://doi.org/10.1001/jamapediatrics.2019.3310CrossRefPubMedPubMedCentral

Gallibois CM, Jawa NA, Noone DG (2017) Hypertension in pediatric patients with chronic kidney disease: management challenges. Int J Nephrol Renovasc Dis 10:205–213. https://doi.org/10.2147/IJNRD.S100891CrossRefPubMedPubMedCentral

Brady TM, Solomon BS, Neu AM et al (2010) Patient-, provider-, and clinic-level predictors of unrecognized elevated blood pressure in children. Pediatrics 125:e1286-1293. https://doi.org/10.1542/peds.2009-0555CrossRefPubMed

Moin A, Mohanty N, Tedla YG et al (2020) Under-recognition of pediatric hypertension diagnosis: Examination of 1 year of visits to community health centers. J Clin Hypertens (Greenwich) 23:257–264. https://doi.org/10.1111/jch.14148CrossRefPubMed

Barletta G-M, Pierce C, Mitsnefes M et al (2018) Is blood pressure improving in children with chronic kidney disease? Hypertension 71:444–450. https://doi.org/10.1161/HYPERTENSIONAHA.117.09649CrossRefPubMed

Kasanagottu K, Mukamal KJ, Landon BE (2024) Predictors of treatment intensification in uncontrolled hypertension. J Hypertens 42:283–291. https://doi.org/10.1097/HJH.0000000000003598CrossRefPubMed

10.

Jain A, Abramovitz B, Desilva R (2022) Applying standard AOBP measurements in a CKD Clinic and its effect on nephrologists’ hypertension management inertia. Am J Kidney Dis 79:S108. https://doi.org/10.1053/j.ajkd.2022.01.360CrossRef

11.

Arakawa K, Imazu R, Morinaga Y et al (2023) Clinical inertia in the hypertensive patients treated by hypertension specialists. J Hypertens 41:e482. https://doi.org/10.1097/01.hjh.0000917832.54573.ccCrossRef

12.

van der Linden EL, Agyemang C, van den Born B-JH (2020) Hypertension control in sub-Saharan Africa: Clinical inertia is another elephant in the room. J Clin Hypertens 22:959–961. https://doi.org/10.1111/jch.13874CrossRef

13.

Milman T, Joundi RA, Alotaibi NM, Saposnik G (2018) Clinical inertia in the pharmacological management of hypertension. Medicine (Baltimore) 97:e11121. https://doi.org/10.1097/MD.0000000000011121CrossRefPubMed

14.

Khoury PR, Mitsnefes M, Daniels SR, Kimball TR (2009) Age-specific reference intervals for indexed left ventricular mass in children. J Am Soc Echocardiogr 22:709–714. https://doi.org/10.1016/j.echo.2009.03.003CrossRefPubMed

15.

Flynn JT, Daniels SR, Hayman LL et al (2014) Update: Ambulatory Blood Pressure Monitoring in Children and Adolescents. Hypertension 63:1116–1135. https://doi.org/10.1161/HYP.0000000000000007CrossRefPubMed

16.

National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576. https://doi.org/10.1542/peds.114.S2.ivCrossRef

17.

Flynn JT, Kaelber DC, Baker-Smith CM et al (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140:e20171904. https://doi.org/10.1542/peds.2017-1904CrossRefPubMed

18.

Lee J, McCulloch CE, Flynn JT et al (2020) Prognostic value of ambulatory blood pressure load in pediatric CKD. Clin J Am Soc Nephrol 15:493–500. https://doi.org/10.2215/CJN.10130819CrossRefPubMedPubMedCentral

19.

Hamdani G, Mitsnefes MM, Flynn JT et al (2021) Pediatric and adult ambulatory blood pressure thresholds and blood pressure load as predictors of left ventricular hypertrophy in adolescents. Hypertension 78:30–37. https://doi.org/10.1161/HYPERTENSIONAHA.120.16896CrossRefPubMed

20.

Parekh RS, Carroll CE, Wolfe RA, Port FK (2002) Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 141:191–197. https://doi.org/10.1067/mpd.2002.125910CrossRefPubMed

21.

Mitsnefes MM (2002) Pediatric end-stage renal disease: heart as a target. J Pediatr 141:162–164. https://doi.org/10.1067/mpd.2002.126921CrossRefPubMed

22.

Sarnak MJ, Levey AS, Schoolwerth AC et al (2003) Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108:2154–2169. https://doi.org/10.1161/01.CIR.0000095676.90936.80CrossRefPubMed

23.

ESCAPE Trial Group, Wühl E, Trivelli A et al (2009) Strict blood-pressure control and progression of renal failure in children. N Engl J Med 361:1639–1650. https://doi.org/10.1056/NEJMoa0902066CrossRef

24.

Wilson AC, Flynn JT (2020) Blood pressure in children with chronic kidney disease: Lessons learned from the Chronic Kidney Disease in Children Cohort Study. Pediatr Nephrol 35:1203–1209. https://doi.org/10.1007/s00467-019-04288-6CrossRefPubMed

25.

Santer M, Ring N, Yardley L et al (2014) Treatment non-adherence in pediatric long-term medical conditions: systematic review and synthesis of qualitative studies of caregivers’ views. BMC Pediatr 14:63. https://doi.org/10.1186/1471-2431-14-63CrossRefPubMedPubMedCentral

26.

Pruette CS, Coburn SS, Eaton CK et al (2019) Does a multimethod approach improve identification of medication nonadherence in adolescents with chronic kidney disease? Pediatr Nephrol 34:97–105. https://doi.org/10.1007/s00467-018-4044-xCrossRefPubMed

27.

Kleinsinger F (2018) The Unmet Challenge of Medication Nonadherence. Perm J 22:18–033. https://doi.org/10.7812/TPP/18-033CrossRefPubMedPubMedCentral

28.

Bismar N, Barlow SE, Brady TM, Turer CB (2020) Pediatrician communication about high blood pressure in children with overweight/obesity during well-child visits. Acad Pediatr 20:776–783. https://doi.org/10.1016/j.acap.2019.11.012CrossRefPubMed

29.

Aujoulat I, Jacquemin P, Rietzschel E et al (2014) Factors associated with clinical inertia: an integrative review. Adv Med Educ Pract 5:141–147. https://doi.org/10.2147/AMEP.S59022CrossRefPubMedPubMedCentral

30.

Zheutlin AR, Mondesir FL, Derington CG et al (2022) Analysis of therapeutic inertia and race and ethnicity in the Systolic Blood Pressure Intervention Trial: a secondary analysis of a randomized clinical trial. JAMA Netw Open 5:e2143001. https://doi.org/10.1001/jamanetworkopen.2021.43001CrossRefPubMedPubMedCentral

Titel: Clinician response after receipt of abnormal pediatric ambulatory blood pressure monitoring – characteristics associated with inertia and action
verfasst von: Evelien van Gelderen
Kevin J. Psoter
Rafi Faria
Cozumel Pruette
Tammy M. Brady
Publikationsdatum: 18.05.2024
Verlag: Springer Berlin Heidelberg
Erschienen in: Pediatric Nephrology
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-024-06404-7

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Clinician response after receipt of abnormal pediatric ambulatory blood pressure monitoring – characteristics associated with inertia and action

Abstract

Background

Methods

Results

Conclusions

Graphical abstract

Neu im Fachgebiet Pädiatrie

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Bei Amblyopie früher abkleben als bisher empfohlen?

Update Pädiatrie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Graphical abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Pädiatrie

Ähnliche Überlebensraten nach Reanimation während des Transports bzw. vor Ort

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

Begünstigt Bettruhe der Mutter doch das fetale Wachstum?

Bei Amblyopie früher abkleben als bisher empfohlen?

Update Pädiatrie